Summary: The National MS Society's National Medical Advisory Committee has issued its recommendations for MS disease-modifying therapies and the coronavirus (COVID-19), and we're sharing them in this episode. You'll also hear about a new disease-modifying therapy that's about to receive FDA approval. And we'll tell you about study results that indicate there are still a lot of people living with MS who aren't acting in their own best interest.
